Literature DB >> 10359654

Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.

D J Watson1, D J Selkoe, D B Teplow.   

Abstract

Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D), is a cerebral amyloidosis characterized by prominent vascular deposits and fatal haemorrhages. The disorder is caused by a point mutation in codon 693 of the gene encoding the amyloid precursor protein (APP), resulting in a Glu-->Gln amino acid substitution at position 22 of the amyloid beta-protein (Abeta) region. The pathogenetic mechanisms of HCHWA-D are unknown but could involve alterations in the proteolytic processing of APP and in amyloid fibril formation. We examined Abeta production and stability by using cultured human embryonic kidney 293 cells stably expressing wild-type or 'Dutch' APP. Radiosequencing and quantitative immunoprecipitation experiments showed that cells expressing Dutch APP secreted increased quantities of Abeta peptides beginning at Asp1, and of truncated peptides beginning at Val18 and Phe19. The ratio of levels of 4 kDa (Abeta) to 3 kDa (p3) peptides remained constant due to co-ordinate decreases in other peptide species. Novel truncated or elongated peptides were not observed. Pulse-chase experiments showed that the Dutch mutation did not affect the stability of the Abeta or p3 populations. These results are consistent with a disease process in which the Dutch mutation results in the production of Abeta peptides with enhanced propensities for fibrillogenesis, leading to accelerated vascular deposition and disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359654      PMCID: PMC1220301     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  58 in total

Review 1.  Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Annu Rev Cell Biol       Date:  1994

2.  Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor.

Authors:  C Haass; A Y Hung; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

3.  Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

Authors:  T Iwatsubo; A Odaka; N Suzuki; H Mizusawa; N Nukina; Y Ihara
Journal:  Neuron       Date:  1994-07       Impact factor: 17.173

4.  Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

Authors:  M Tabaton; M G Nunzi; R Xue; M Usiak; L Autilio-Gambetti; P Gambetti
Journal:  Biochem Biophys Res Commun       Date:  1994-05-16       Impact factor: 3.575

5.  APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain.

Authors:  A Tamaoka; A Odaka; Y Ishibashi; M Usami; N Sahara; N Suzuki; N Nukina; H Mizusawa; S Shoji; I Kanazawa
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

6.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

Authors:  N Suzuki; T T Cheung; X D Cai; A Odaka; L Otvos; C Eckman; T E Golde; S G Younkin
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

7.  Secretory cleavage site of Alzheimer amyloid precursor protein is heterogeneous in Down's syndrome brain.

Authors:  F Kametani; K Tanaka; T Tokuda; S Ikeda
Journal:  FEBS Lett       Date:  1994-09-05       Impact factor: 4.124

8.  Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Authors:  M Citron; C Vigo-Pelfrey; D B Teplow; C Miller; D Schenk; J Johnston; B Winblad; N Venizelos; L Lannfelt; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

9.  Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

Authors:  T C Saido; T Iwatsubo; D M Mann; H Shimada; Y Ihara; S Kawashima
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

10.  Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

Authors:  A Clements; D M Walsh; C H Williams; D Allsop
Journal:  Neurosci Lett       Date:  1993-10-14       Impact factor: 3.046

View more
  16 in total

1.  Association thermodynamics and conformational stability of beta-sheet amyloid beta(17-42) oligomers: effects of E22Q (Dutch) mutation and charge neutralization.

Authors:  Nikolay Blinov; Lyudmyla Dorosh; David Wishart; Andriy Kovalenko
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

2.  Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

Authors:  Elizabeth A Yates; Elena M Cucco; Justin Legleiter
Journal:  ACS Chem Neurosci       Date:  2011-04-11       Impact factor: 4.418

3.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 4.  Impact of a discordant helix on β-amyloid structure, aggregation ability and toxicity.

Authors:  Yi-Cheng Chen
Journal:  Eur Biophys J       Date:  2017-07-07       Impact factor: 1.733

5.  Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types.

Authors:  A K Sian; E R Frears; O M El-Agnaf; B P Patel; M F Manca; G Siligardi; R Hussain; B M Austen
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

6.  Point mutations in Aβ result in the formation of distinct polymorphic aggregates in the presence of lipid bilayers.

Authors:  Phillip M Pifer; Elizabeth A Yates; Justin Legleiter
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

7.  Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.

Authors:  Samir Kumar-Singh; Patrick Cras; Rong Wang; John M Kros; Johan van Swieten; Ursula Lübke; Chantal Ceuterick; Sally Serneels; Krist'l Vennekens; Jean-Pierre Timmermans; Eric Van Marck; Jean-Jacques Martin; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?

Authors:  Andrew J Beel; Charles K Mobley; Hak Jun Kim; Fang Tian; Arina Hadziselimovic; Bing Jap; James H Prestegard; Charles R Sanders
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

9.  Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant.

Authors:  Francesca Massi; D Klimov; D Thirumalai; John E Straub
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

10.  Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

Authors:  Panagiotis Fotiadis; Sanneke van Rooden; Jeroen van der Grond; Aaron Schultz; Sergi Martinez-Ramirez; Eitan Auriel; Yael Reijmer; Anna M van Opstal; Alison Ayres; Kristin M Schwab; Trey Hedden; Jonathan Rosand; Anand Viswanathan; Marieke Wermer; Gisela Terwindt; Reisa A Sperling; Jonathan R Polimeni; Keith A Johnson; Mark A van Buchem; Steven M Greenberg; M Edip Gurol
Journal:  Lancet Neurol       Date:  2016-05-11       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.